Sanofi India

BSE: 500674 | NSE: SANOFI | ISIN: INE058A01010 | SECTOR: Biotechnology & Drugs

₹ 8,570.00

-109.45 (-1.26%)
03 May 2024, 01:23 PM IST
View all metrics

Key Metrics

Influencer Count

-

Simple Moving Averages

DaysBSENSE

58,241.188,242.98
108,269.698,272.24
208,380.458,381.87
508,417.678,418.21
1008,393.868,394.82
3007,847.027,849.04

News

View all

Company Description

Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.

Company Officers